KR101816638B1 - Oral composition comprising saponin extracted from the root of Camellia sinensis - Google Patents
Oral composition comprising saponin extracted from the root of Camellia sinensis Download PDFInfo
- Publication number
- KR101816638B1 KR101816638B1 KR1020110099525A KR20110099525A KR101816638B1 KR 101816638 B1 KR101816638 B1 KR 101816638B1 KR 1020110099525 A KR1020110099525 A KR 1020110099525A KR 20110099525 A KR20110099525 A KR 20110099525A KR 101816638 B1 KR101816638 B1 KR 101816638B1
- Authority
- KR
- South Korea
- Prior art keywords
- root
- composition
- chemical formula
- tea
- saponin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 CC(C)(CC([C@]1(CO)[C@]2OC(C(C)=CC)=O)C3=CCC([C@@](C)(CC4)C(CC5)[C@](C)(CO)C4OC(C(C4OC(C(C6O)O)OCC6O)O)OC(*)C4O)[C@]5(C)[C@]3(C)C[C@]1OC(C)=O)[C@]2OC(C)=O Chemical compound CC(C)(CC([C@]1(CO)[C@]2OC(C(C)=CC)=O)C3=CCC([C@@](C)(CC4)C(CC5)[C@](C)(CO)C4OC(C(C4OC(C(C6O)O)OCC6O)O)OC(*)C4O)[C@]5(C)[C@]3(C)C[C@]1OC(C)=O)[C@]2OC(C)=O 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 차나무 뿌리 유래 사포닌을 포함하는 구강용 조성물에 관한 것으로, 더욱 상세하게는 차나무 뿌리에서 추출한 트리테르페노이드 사포닌을 포함함으로써 치은염 또는 치주염과 같은 치주질환을 효과적으로 예방 또는 치료하고, 구취를 억제 또는 개선할 수 있는 효능이 우수한 구강용 조성물에 관한 것이다.The present invention relates to an oral composition comprising saponin derived from root of tea, and more particularly to a composition for preventing or treating periodontal disease such as gingivitis or periodontitis by containing triterpenoid saponin extracted from a root of tea, Or an oral composition which is excellent in improving the efficacy.
Description
본 발명은 사포닌을 유효성분으로 포함하는 구강 조성물에 관한 것이다. The present invention relates to an oral composition comprising saponin as an active ingredient.
보다 상세하게는, 트리테르페노이드 사포닌, 바람직하게는 차나무 뿌리에서 추출한 트리테르페노이드 사포닌을 유효성분으로 포함하여 부작용을 최소화하고 우수한 항염 효과를 가지는 치주질환 개선용 및 구취 억제용 구강용 조성물에 관한 것이다.More particularly, the present invention relates to a composition for oral care for reducing periodontal disease and having an excellent anti-inflammatory effect by minimizing side effects and containing triterpenoid saponin, preferably triterpenoid saponin extracted from a root of tea, as an active ingredient .
치아는 인산칼슘(Calcium phosphate)으로 이루어진 무기질로서 그 질환에는 크게 충치와 치주질환이 있다. 이중 충치는 어린이부터 성인까지 치과질병의 가장 큰 부분을 차지하고 있으며 발생빈도가 높아지고 있다. 대한치과의사협회의 보고에 따르면, 아동의 90% 이상이 치아 우식(Dental caries)을 경험하며, 성인의 80% 이상이 치주질환을 갖고 있다고 한다. The teeth are minerals made of calcium phosphate. The diseases are mainly tooth decay and periodontal diseases. Dental cavities are the largest part of dental disease from childhood to adult and are increasing in frequency. According to the Korean Dental Association, more than 90% of children experience dental caries and more than 80% of adults have periodontal disease.
일반적으로 치주질환을 예방하기 위하여 고안된 구강용 조성물에는 염화나트륨, 알란토인클로로히드록시 알루미늄, 아미노카프론산, 초산토코페롤 등 합성원료들이 그 주를 이루고 있었다. 그러나, 최근 치·의학계에서는 천연식물 등을 이용한 민간전통의학의 효용성을 찾고 극대화하기 위한 수많은 연구가 이루어지고 있으며, 구강에의 효과들이 알려지면서 많은 추출물들이 치주질환 개선용 및 구취 억제용 구강 조성물에 응용되고 있다.In general, oral compositions designed to prevent periodontal disease include sodium chloride, allantoin chlorohydroxy aluminum, aminocaproic acid, and tocopherol acetate. However, in recent years, in the field of dentistry and medicine, numerous studies have been conducted to find out and maximize the utility of traditional traditional medicine using natural plants. As the effects on oral cavity have been known, many extracts have been used in oral compositions for improving periodontal disease Has been applied.
국내공개특허 제2002-0087672호는 정향 추출물을 함유하고 있어 입안 가글시 청량감을 제공할 뿐만 아니라 항균활성으로 인한 구취제거 및 치주질환을 예방하는데 뛰어난 효과가 있고 기존의 청정제가 지니지 못한 진통효과를 가지고 있다는 사실이 개시되어 있다.Korean Patent Publication No. 2002-0087672 has an excellent effect in removing bad breath due to antibacterial activity and preventing periodontal disease as well as providing a refreshing sensation in mouth gargle because it contains clove extract and has an analgesic effect not possessed by conventional detergents ≪ / RTI >
국내공개특허 제2002-0066042호는 석류추출물을 함유한 구강 위생 증진용 조성물에 관한 것으로서, 석류 추출물이 활성산소와 산화질소 생성을 억제시키는 작용이 우수함을 확인하여 이러한 항산화 효능을 통하여 구강위생을 증진시키는데 역할이 뛰어나다는 사실이 개시되어 있다.Korean Patent Publication No. 2002-0066042 relates to a composition for enhancing oral hygiene containing pomegranate extract, wherein the pomegranate extract has excellent antioxidative and antioxidant activity and thus promotes oral hygiene through the antioxidant effect The role is excellent.
국내공개특허 제2001-0036152호는 식물추출물 파우더의 제조 방법 및 이 방법에 의해 제조된 식물추출물 파우더를 함유하는 구강용 조성물에 관한 것으로서, 인공적인 항생제, 살균제보다 민간에서 널리 알려져 온 약용 식물 추출물, 특히 솔잎을 사용하여 구강 내에서 우수한 치주질환 및 충치예방효과를 제공할 수 있다고 개시되어 있다.Korean Patent Laid-Open Publication No. 2001-0036152 discloses a method for preparing a plant extract powder and an oral composition containing a plant extract powder prepared by the method. The present invention relates to a composition for oral use which is widely known in the arts than artificial antibiotics and fungicides, In particular, it is disclosed that pine needle can be used to provide excellent periodontal disease and tooth decay prevention effect in the oral cavity.
상기에서 살펴본 바와 같이, 많은 식물추출물들이 구강위생의 증진목적으로 배합되어 사용되어오고 있으나, 대개의 경우 빈약한 항균 효과를 가지거나 단순히 소염, 수렴, 지혈, 혈액순환 촉진과 같은 추상적인 효능을 통하여 치주질환의 발생을 예방한다는 정도만을 나타내고 있으며, 안정도 면에서 미흡한 단점이 있어 구강용 조성물로 사용하는데 어려움이 있었다.As mentioned above, many plant extracts have been used for the purpose of promoting oral hygiene. However, in most cases, they have a poor antimicrobial effect or they simply have abstract effects such as anti-inflammation, convergence, hemostasis, and promotion of blood circulation It shows only a degree of prevention of periodontal disease occurrence, and it has disadvantages in that it is insufficient in terms of stability, so that it has been difficult to use it as an oral composition.
이에, 본 발명자들은 차의 다양한 생리활성 연구를 수행하던 중 차나무의 뿌리부분에서 추출한 사포닌이 구강 내 염증을 억제하여 치주질환의 개선 및 구취 억제에 유용하게 사용할 수 있음을 발견하여 본 발명을 완성하였다.Accordingly, the inventors of the present invention discovered that saponin extracted from the root portion of tea leaves can be used for the prevention of periodontal disease and inhibition of bad breath by inhibiting inflammation in the oral cavity during the study of various physiological activities of tea. .
이에 본 발명자들은 치주질환 예방 및 치료를 위해서 여러 식물추출물들을 조사하여 분석한 결과, 차나무 뿌리에서 추출한 트리테르페노이드 사포닌이 우수한 항염 효과를 갖고 천연물을 사용하여 부작용이 없음을 발견하고 본 발명을 완성하였다. Accordingly, the present inventors investigated and analyzed various plant extracts for the prevention and treatment of periodontal disease. As a result, they found that triterpenoid saponins extracted from tea roots had excellent antiinflammatory effect and had no side effects using natural products. Respectively.
따라서, 본 발명의 목적은 차나무 뿌리에서 추출한 트리테르페노이드 사포닌을 유효성분으로 함유하여 우수한 항염효과를 갖는 치주질환의 개선 및 구취 억제용 구강 조성물을 제공하는 것이다.Accordingly, an object of the present invention is to provide an oral composition for improving periodontal disease and inhibiting bad breath, which contains triterpenoid saponin extracted from a root of tea as an active ingredient and has excellent anti-inflammatory effect.
상기한 목적을 달성하기 위하여, 본 발명은 차나무 뿌리에서 추출한 트리테르페노이드 사포닌을 유효성분으로 포함하는 치주질환의 개선 및 구취 억제용 구강 조성물을 제공한다.In order to achieve the above object, the present invention provides an oral composition for improving periodontal disease and inhibiting bad breath, comprising triterpenoid saponin extracted from a root of tea, as an active ingredient.
본 발명의 조성물은 차나무 뿌리에서 추출한 트리테르페노이드 사포닌을 유효성분으로 포함함으로써 항염효과가 있고, 따라서 치주질환을 예방 또는 치료하고 구취를 억제 또는 개선할 수 있다.The composition of the present invention has an anti-inflammatory effect by containing triterpenoid saponin extracted from the root of tea as an active ingredient, thus preventing or treating periodontal disease and suppressing or improving bad breath.
도 1은 피검자 120명을 대상으로 치면 착색 정도를 통해 차나무 뿌리에서 유래한 트리테르페노이드 사포닌 조성물을 이용한 군의 치면 세균막 지수를 대조군과 비교하여 나타낸 그래프이다.
도 2는 피검자 120명을 대상으로 차나무 뿌리에서 유래한 트리테르페노이드 사포닌 조성물을 이용한 군의 치은염 지수를 대조군과 비교하여 나타낸 그래프이다.
도 3은 피검자 120명을 대상으로 차나무 뿌리에서 유래한 트리테르페노이드 사포닌 조성물을 이용한 군의 구취 발생 지수를 대조군과 비교하여 나타낸 그래프이다.FIG. 1 is a graph showing the tooth surface bacterial film index of a group using a triterpenoid saponin composition derived from a root of a tea plant through comparison with a control group, based on the degree of coloring of teeth of 120 subjects.
FIG. 2 is a graph showing the gingival index of a group using a triterpenoid saponin composition derived from a root of tea from 120 subjects in comparison with a control group. FIG.
FIG. 3 is a graph showing the odor occurrence index of a group of 120 subjects, using a triterpenoid saponin composition derived from a root of tea, in comparison with a control group.
본 발명은 차나무 뿌리 유래 사포닌(saponin)을 유효성분으로 포함하는 구강용 조성물을 제공한다.The present invention provides an oral composition comprising tea sap root derived saponin as an active ingredient.
본 발명에서 유효성분으로 이용되는 차나무 뿌리 유래 사포닌은 바람직하게는 차나무 뿌리의 추출물에서 분리한 트리테르페노이드 사포닌을 유효성분으로 포함하며, 상기 트리테르페노이드 사포닌은 치주질환을 예방 및 개선할 뿐 아니라 구취를 억제 및 개선하는 효과가 있다.The saponin derived from tea root used as an active ingredient in the present invention preferably contains triterpenoid saponin isolated from the extract of tea root, and the triterpenoid saponin prevents and improves periodontal disease But also has the effect of suppressing and improving bad breath.
본 발명에서 사용되는 트리테르페노이드 사포닌은 차나무 뿌리의 메탄올 추출물에서 분리한 10종류의 사포닌이며, 본 발명에서는 이를 각각 '차나무 뿌리 유래 사포닌 R1 내지 R10'로 지칭한다. 이들 차나무 뿌리 유래 사포닌 R1 내지 R10은 하기 화학식 1 내지 10의 구조를 가진다.The triterpenoid saponins used in the present invention are ten kinds of saponins isolated from the methanol extract of the tea root, and they are referred to as 'saponin R1 to R10' derived from the root of tea. The saponins R1 to R10 derived from these tea root roots have the following formulas (1) to (10).
본 발명의 조성물은 상기 트리테르페노이드 사포닌을 조성물 총 중량에 대하여 0.01~65중량%의 양으로 포함하는 것이 바람직하다. 이는 상기 유효성분의 함량이 0.01중량% 미만이 경우에는 그 효과가 나타나기 어렵고, 65중량%를 초과할 경우에는 함량 의존적으로 효과가 증대하지 않고 구강 점막에 자극을 줄 수 있다.The composition of the present invention preferably contains the triterpenoid saponin in an amount of 0.01 to 65% by weight based on the total weight of the composition. If the content of the active ingredient is less than 0.01% by weight, the effect is less likely to be exhibited. If the content is more than 65% by weight, irritation may be given to the oral mucosa without increasing the content-dependent effect.
치아는 무기질인 인산칼슘(Calcium phosphate)이 주 구성성분이며, 약 200~300여종의 미생물이 치아표면, 치근부의 치아와 잇몸 사이, 혀의 표면에 상주하는 것으로 알려져 있다. 구강 위생 활동이 적절히 이루어지지 않은 경우에는 스트렙토코커스(Streptococcus) 계통의 미생물이 생산하는 유기산에 의해 인산칼슘으로 구성된 치아 경조직을 손상시켜, 충치, 치은염과 같은 각종 치주질환을 발생시킬 뿐 아니라 미생물이 음식물 유래의 아미노산을 탈회산 효소나 아미노 효소 등을 통해 악취를 유발하는 물질인 휘발성 황화물(volatile sulfide compounds)을 생성함으로써 구취를 발생시키게 된다. 따라서 페니실린과 같은 항생제를 이용하여 유해 미생물 증식에 의해 발생하는 치주질환을 감소시킬 수 있다는 보고가 있지만 장기간 사용시 항생제 내성이 발생할 수 있으므로 임상에서는 사용되지 않고 있다. The teeth are composed of inorganic calcium phosphate (calcium phosphate), and about 200 ~ 300 kinds of microorganisms are known to reside on the surface of the tooth, between the tooth and gum of the root, and on the surface of the tongue. If the oral hygiene activities are not properly performed, the tooth hard tissues composed of calcium phosphate are damaged by the organic acids produced by the microorganisms of the Streptococcus strains, causing various periodontal diseases such as tooth decay and gingivitis, It produces volatile sulfide compounds, which are substances that cause odors through amino acids derived from deacylation enzymes and amino enzymes. Therefore, it is reported that antibiotics such as penicillin can reduce the periodontal disease caused by the growth of harmful microorganisms, but it is not used in the clinic since antibiotic resistance may occur during long-term use.
차나무 뿌리 유래 트리테르페노이드 사포닌은 비 항생제로써 부작용 없이 치아 우식증을 발생시키는 스트렙토코커스 뮤탄스(Streptococcus mutans) 및 대표적인 치주질환 관련균인 포피로모나스 진지발리스(Porphyromonas gingivalis) 에 대하여 항균력을 가질 뿐만 아니라 스트렙토코커스 뮤탄스가 치아 우식을 유발하는 과정의 핵심효소인 글로코실트랜스퍼라아제(glucosyltransferase)를 저해하는 효과가 있는 것으로 나타났다. 또한 구강 미생물에 대한 항균 활성을 통해 구취 물질이 발생하는 현상을 감소시키는 것으로 확인되었다.Triterpenoid saponins derived from tea root roots are non-antibiotics and have the potential to cause dental caries without side effects. Streptococcus mutans mutans ) and representative periodontal disease-related bacteria, Porphyromonas gingivalis ), as well as inhibiting glucosyltransferase, a key enzyme in the process of causing dental caries in Streptococcus mutans. It was also confirmed that the antimicrobial activity against oral microorganisms reduces the occurrence of halitosis substances.
본 발명의 구강용 조성물은 그 제형에 있어서 특별히 한정되지 않으며, 구체적인 예를 들면, 치약, 구강용 세정제, 구강 청정제 등의 제형을 가질 수 있다.The composition for oral use of the present invention is not particularly limited in its formulation, and specific examples thereof may include formulations such as toothpaste, mouthwash, mouthwash, and the like.
예를 들면, 치약류의 경우에는 당업계에서 통상적으로 사용되는 연마제, 습윤제, 기포제, 결합제, 감미제, pH 조절제, 방부제, 약효성분, 향료, 증백제, 색소, 용제 등을 함유할 수 있다.For example, in the case of dentifrices, it may contain abrasives, wetting agents, foaming agents, binders, sweeteners, pH adjusting agents, preservatives, medicinal active ingredients, flavoring agents, whitening agents, pigments and solvents commonly used in the art.
연마제 성분으로는 탄산칼슘, 침강 실리카, 수산화알루미늄, 인산일수소칼슘 및 불용성 메타인산나트륨 등이 있으며, 이들 연마제를 단독 혹은 2종 이상 혼합하여 조성물 총 중량에 대하여 1~60 중량%, 바람직하게는 10~50 중량%를 사용한다.Examples of the abrasive component include calcium carbonate, precipitated silica, aluminum hydroxide, calcium monohydrogenphosphate and insoluble sodium metaphosphate. These abrasives may be used alone or in admixture of two or more, and may be used in an amount of 1 to 60% by weight, 10 to 50% by weight is used.
습윤제 성분으로는 글리세린, 소르비톨액, 폴리에틸렌글리콜 및 프로필렌글리콜 등이 있으며 단독 또는 2종 이상 혼합하여 20~60 중량% 사용한다.Examples of the wetting agent component include glycerin, sorbitol solution, polyethylene glycol and propylene glycol, and they are used alone or in admixture of 20 to 60% by weight.
기포제로는 라우릴황산나트륨, 소디움라우릴사르코시네이트, 자당지방산에스테르, 폴리옥시에틸렌경화피마자유 및 폴리옥시에틸렌폴리옥시프로피렌공중합체 등의 음이온 및 비이온 계면활성제를 단독 혹은 2종 이상 혼합하여 0.5~5 중량%, 바람직하게는 0.5~3 중량%를 사용한다.Examples of the foaming agent include anionic and nonionic surfactants such as sodium lauryl sulfate, sodium lauryl sarcosinate, sucrose fatty acid ester, polyoxyethylene hardened castor oil, and polyoxyethylene polyoxypropylene copolymer, either singly or in combination 0.5 to 5 wt%, preferably 0.5 to 3 wt% is used.
결합제로서는 카르복시메칠 셀룰로오스 나트륨, 하이드록시메칠셀룰로오스, 카라기난, 잔탄검 및 알긴산 나트륨 등을 단독 혹은 2종 이상 혼합하여 0.1~5 중량%, 바람직하게는 0.1~2 중량%를 사용한다.As the binder, 0.1 to 5% by weight, preferably 0.1 to 2% by weight, of sodium carboxymethylcellulose, hydroxymethylcellulose, carrageenan, xanthan gum and sodium alginate are used alone or in admixture of two or more.
감미제로서는 삭카린나트륨, 아스파탐, 스테비오사이드, 자일리톨 및 감초산 등을 단독 혹은 2종 이상 혼합하여 0.05~5 중량%를 사용하는 것이 좋다.As the sweetening agent, it is preferable to use 0.05 to 5% by weight of sodium saccharin, aspartame, stevioside, xylitol and licorice acid, alone or in admixture of two or more.
pH 조절제로서는 인산나트륨, 인산이나트륨, 인산삼나트륨, 피로인산나트륨, 구연산나트륨, 구연산 및 주석산 등이 있고, 방부제로서는 파라옥시안신향산메칠, 파라옥시안식향산프로필 및 안식향산나트륨을 단독 혹은 2종 이상 혼합하여 사용한다.Examples of the pH adjusting agent include sodium phosphate, disodium phosphate, sodium trisodium phosphate, sodium pyrophosphate, sodium citrate, citric acid and tartaric acid. Examples of the preservative include paraoxybenzoic acid methyl ester, paraoxybenzoic acid ester and sodium benzoate .
약효성분으로는 불화나트륨, 일불소인산나트륨, 불화주석, 클로로헥시딘, 알란토인 클로로히드록시알루미네이트, 아미노카프론산, 트리클로산, 염화세틸피리디움, 염화아연, 염산피리독신 및 초산토코페롤 등을 단독 혹은 2종 이상 혼합하여 사용하고, 향료로는 페퍼민트오일, 스피아민트오일, 멘톨 및 아네톨 등을 적당량 혼합하여 사용하며, 증백제로는 산화티탄을, 색소로는 식용색소를, 정제수 및 에탄올의 용제로 통상의 치약 제조방법에 따라 제조한다.
Examples of the active ingredient include sodium fluoride, sodium fluorophosphate, tin fluoride, chlorohexidine, allantoin chlorohydroxy aluminate, aminocaproic acid, triclosan chloride, cetylpyridinium chloride, zinc chloride, pyridoxine hydrochloride and tocopheryl acetate. A mixture of two or more of them is used as a flavor enhancer, and an appropriate amount of peppermint oil, spearmint oil, menthol and anethole is mixed and used as a flavor. Titanium oxide is used as a brightener, an edible pigment is used as a pigment, It is prepared according to a conventional toothpaste manufacturing method.
이하, 하기 실시예에 의하여 본 발명을 더욱 상세하게 설명하고자 한다. 단, 하기 실시예는 본 발명을 예시하기 위한 것일 뿐 본 발명의 범위가 이들만으로 한정되는 것은 아니다
Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the following examples are intended to illustrate the present invention, but the scope of the present invention is not limited thereto
[참고예 1] 차나무 뿌리 유래 사포닌의 분리[Referential Example 1] Separation of Saponins Derived from Root Roots
차나무의 뿌리는 2005년 11월에 제주도 서귀포시 남원읍 한남리에서 수집하였으며, 차나무는 야부기다(Yabukita) 품종으로 20년 된 것을 선택하였다. The root of the tea was collected in November, 2005 in Nam - ri, Namwon - eup, Seogwipo city, Jeju - do, and the tea tree was selected as Yabukita variety 20 years old.
신선한 차나무 뿌리 10kg을 작은 조각으로 자르고 80%의 수성 MeOH 8L에 담그어 2일 동안 실온에 두었고, 이러한 추출 방법을 2번 반복하였다. 추출물을 합하고, 진공 하에서 농축시켜 고무질의 갈색 잔여물 540g을 수득하였다. 잔여물 100g을 C18 실리카겔 플래시 컬럼(flash column)에서 용리액으로 H2O(각각 4L) 내의 MeOH를 0 내지 100%로 10%씩 증가시킨 것을 사용하여 크로마노크래피로 분리하고 11개의 분획물(A 내지 K)을 얻었다. 이 중 활성인 분획물 G(4g) 및 H(10g)를 합하고, 실리카겔 컬러에서 다시 크로마토그래피를 실시하여 8개의 분획물(GH1 내지 GH8)을 얻었다.10 kg of fresh tea roots were cut into small pieces and soaked in 8 L of 80% aqueous MeOH and left at room temperature for 2 days, and this extraction method was repeated twice. The extracts were combined and concentrated in vacuo to give 540 g of gummy brown residue. 100 g of the residue was chromatographed on a C18 silica gel flash column using 10% increments of MeOH in H 2 O (4 L each) from 0 to 100% as eluent to yield 11 fractions K). The active fractions G (4 g) and H (10 g) were combined and chromatographed again on silica gel color to obtain eight fractions (GH1 to GH8).
분획물 중 효소 억제 사포닌 분획물인 GH5(1.02g)를 C18 HPLC(용리액 B; 50~60% 수성 MeCN)로 정제하여 9개의 사포닌인 1(108mg, tR 19.9분), 2(92mg, tR 20.9분), 3(37mg, tR 23.3분), 4(60mg, tR 32.7분), 5(161mg, tR 35.7분), 6(113mg, tR 37.8분), 7(48mg, tR 39.4분), 8(33mg, tR 41.9분), 및 9(56mg, tR 47.9분)를 획득하였다. 또한 C18 HPLC에서 용리액 A(40~49% 수성 MeCN)를 사용하여 분석 샘플 1~3을, 용리액 D(70~80% 수성 MeOH)를 사용하여 샘플 4~8을 수득하였다(각각 49mg, 32mg, 12mg, 16mg, 71mg, 20mg, 12mg, 및 9mg). 상기 분획물 9는 HPLC로 용리액 C(55~60% 수성 MeCN)를 사용하여 추가 정제하였고, 분석 샘플 9(26mg, tR 43.3분) 및 10(8mg, tR 62.7분)를 수득하였다.
GH5 (1.02 g), an enzyme-inhibiting saponin fraction, was purified by C18 HPLC (eluent B; 50 to 60% aqueous MeCN) to give 9 saponins, 1 (108 mg, t R 19.9 bun), 2 (92mg, t R 20.9 bun), 3 (37mg, tR < / RTI > 23.3 min), 4 (60 mg, t R 32.7 min), 5 (161 mg, t R 35.7 min), 6 (113 mg, t R 37.8 min), 7 (48 mg, t R was obtained 39.4 min), 8 (33mg, t R 41.9 min), and 9 (56mg, t R 47.9 min). Samples 4-8 were also obtained on C18 HPLC using Eluent A (40-49% aqueous MeCN) and Eluent D (70-80% aqueous MeOH) using analytical samples 1-3 (49 mg, 32 mg, 12 mg, 16 mg, 71 mg, 20 mg, 12 mg, and 9 mg). The fractions 9, was further purified using eluent C (55 ~ 60% aqueous MeCN) to HPLC, analysis of a sample 9 (26mg, t R 43.3 min) and 10 (8mg, tR < / RTI > 62.7 min).
분리된 10종의 트리테르페노이드 사포닌을 각각 '차나무 뿌리 유래 사포닌 R1 내지 R10'으로 지칭하며, 이에 대한 구체적인 분석 결과는 다음과 같다.The ten separated triterpenoid saponins are referred to as 'saponin root-derived saponins R1 to R10', respectively, and the results of analysis are as follows.
차나무 뿌리 유래 사포닌 R1: 백색 고체; 녹는점 228 - 229℃; [α]20 D : -28.83 (c 0.43, MeOH); IR (neat): νmax = 3406, 1738, 1714, 1447, 1249, 1039 cm-1; 1H-NMR (400 MHz, CD3OD): δ = 0.69 (3H, s, H-24) , 0.87 (3H, t, J = 7.2 Hz, 2MB-H-4), 0.89 (3H, s, H-29), 1.00 (5H, 3H,s, H-25 and 2H, m, H-6), 1.01 (3H, s, H-26), 1.02 (1H, m, Ha-1), 1.03 (3H, d, J = 7.2 Hz, 2MB-H-5), 1.05 (3H, s, H-30), 1.07 (1H, m, Ha-7), 1.26 (1H, t, J = 10.4 Hz, H-5), 1.35 (1H, dd, J = 13.2, 5.2 Hz, Ha-19), 1.38 (1H, m, 2MB-Ha-3), 1.48 (1H, m, Hb-7), 1.50 (3H, s, H-27), 1.56 (1H, m, 2MB-Hb-3), 1.64 (2H, m, Hb-1, H-9), 1.74 (1H, m, Ha-2), 1.84 (1H, m, Hb-2), 1.91 (3H, s, Ac), 1.96 (3H, s, Ac), 1.98 (2H, m, H-11), 2.23 (1H, m, 2MB-H-2), 2.25 (3H, s, Ac), 2.47 (1H, t, J = 14.2 Hz, Hb-19), 2.77 (1H, dd, J = 14.0, 4.0 Hz, H-18), 3.10 (1H, d, J = 11.2 Hz, Ha-28), 3.26 (1H, d, J = 11.2 Hz, Ha-23), 3.36 (1H, d, J = 11.2 Hz, Hb-28), 3.42 (1H, t J = 8.0, Hz, GlcA-H-2), 3.54 (2H, m, GlcA-H-3 & Ara-H-3), 3.57 (1H, m, GlcA-H-4), 3.58 (1H, m, Ara-Ha-5), 3.60 (1H, d, J = 11.2 Hz, Hb-23), 3.62 (1H, m, Ara-H-2), 3.63 (1H, m, H-3), 3.80 (1H, m, Ara-H-4), 3.82 (1H, m, GlcA-H-5), 3.90 (1H, m, Ara-Hb-5), 4.51 (2H, d, J = 7.2 Hz, GlcA-H-1, Ara-H-1), 5.16 (1H, d, J = 4.8 Hz, H-15), 5.29 (1H, d, J = 4.8 Hz, H-16), 5.30 (1H, d, J = 10.0 Hz, H-21), 5.52 (1H, d, J = 10.0 Hz, H-22), 5.59 (1H, brs, H-12); HR-TOF-ESI-MS: m/z = 1041.5258 [M + H]+ (calcd. for C52H80O21 + H: 1041.5270).
Saponin derived from root of tea root R1: white solid; Melting point 228 - 229 ° C; [?] 20 D : -28.83 ( c 0.43, MeOH); IR (neat):? Max = 3406, 1738, 1714, 1447, 1249, 1039 cm -1 ; 1 H-NMR (400 MHz, CD 3 OD): δ = 0.69 (3H, s, H-24), 0.87 (3H, t, J = 7.2 Hz, 2MB-H-4), 0.89 (3H, s, H-29), 1.00 (5H , 3H, s, H-25 and 2H, m, H-6), 1.01 (3H, s, H-26), 1.02 (1H, m, H a -1), 1.03 (3H, d, J = 7.2 Hz, 2MB-H-5), 1.05 (3H, s, H-30), 1.07 (1H, m, H a -7), 1.26 (1H, t, J = 10.4 Hz , H-5), 1.35 ( 1H, dd, J = 13.2, 5.2 Hz, H a -19), 1.38 (1H, m, 2MB-H a -3), 1.48 (1H, m, H b -7) , 1.50 (3H, s, H -27), 1.56 (1H, m, 2MB-H b -3), 1.64 (2H, m, H b -1, H-9), 1.74 (1H, m, H a -2), 1.84 (1H, m , H b -2), 1.91 (3H, s, Ac), 1.96 (3H, s, Ac), 1.98 (2H, m, H-11), 2.23 (1H, m , 2.32 (3H, s, Ac), 2.47 (1H, t, J = 14.2 Hz, H b -19), 2.77 (1H, dd, J = 14.0, 4.0 Hz, ), 3.10 (1H, d, J = 11.2 Hz, H a -28), 3.26 (1H, d, J = 11.2 Hz, H a -23), 3.36 (1H, d, J = 11.2 Hz, H b - H), 3.42 (1H, t, J = 8.0, Hz, GlcA-H-2), 3.54 (2H, m, GlcA- 4), 3.58 (1H, m , Ara-H a -5), 3.60 (1H, d, J = 11.2 Hz, H b -23), 3.62 (1H, m, Ara-H-2), 3.63 (1H , m, H-3), 3.80 (1H, m, Ara- H-4), 3.82 (1H , m, GlcA-H-5), 3.90 (1H, m, Ara-H b -5), 4.51 (2H, d, J = 7.2 Hz, GlcA-H-1, Ara -H-1), 5.16 (1H , d, J = 4.8 Hz, H-15), 5.29 (1H, d, J = 4.8 Hz, H-16), 5.30 (1H, d, J = 10.0 Hz, H -21), 5.52 (1H, d, J = 10.0 Hz, H-22), 5.59 (1H, brs, H-12); HR-TOF-ESI-MS: m / z = 1041.5258 [M + H] + (calcd. For C 52 H 80 O 21 + H: 1041.5270).
차나무 뿌리 유래 사포닌 R2: 백색 고체; 녹는점 229 - 230℃; [α] 20 D : -37.61 (c 0.545, MeOH); IR (neat): νmax = 3314,, 1727, 1444, 1248, 1038 cm-1; 1H-NMR (400 MHz, CD3OD): δ = 0.69 (3H, s, H-24), 0.91 (3H, s, H-29), 1.00 (3H, s, H-25), 1.01 (3H, s, H-26), 1.08 (3H, s, H-30), 1.26 (1H, m, Ha-19), 1.50 (3H, s, H-27), 1.71 (3H, s, Ang-H-5), 1.90 (3H, s, Ac), 1.91 (3H, d, J = 7.6 Hz , Ang-H-4), 1.93 (3H, s, Ac), 2.24 (3H, s, Ac), 2.50 (1H, t, J = 14.0, Hb-19), 2.78 (1H, dd, J = 14.4, 4.0 Hz, H-18), 3.14 (1H, d, J = 10.8 Hz, Ha-28), 3.26 (1H, d, J = 10.8 Hz, Ha-23), 3.39 (1H, d, J = 10.0 Hz, Hb-28), 3.60 (1H, d, J = 10.8 Hz, Hb-23), 3.63 (1H, m, H-3), 4.50 (2H, d, J = 7.2 Hz, GlcA-H-1, Ara-H-1), 5.18 (1H, d, J = 4.4 Hz, H-15), 5.28 (1H, d, J = 4.0 Hz, H-16), 5.38 (1H, d, J = 10.8 Hz, H-21), 5.60 (1H, brs, H-12), 5.61 (1H, d, J = 10.8 Hz, H-22), 6.08 (1H, q, J = 7.6 Hz, Ang-H-3); HR-TOF-ESI-MS: m/z = 1039.5142 [M + H]+ (calcd. for C52H78O21 + H: 1039.5114).
Saponin derived from root of tea root R2: white solid; Melting point 229 - 230 캜; [α] 20 D: -37.61 ( c 0.545, MeOH); IR (neat):? Max = 3314, 1727, 1444, 1248, 1038 cm -1 ; 1 H-NMR (400 MHz, CD 3 OD):? = 0.69 (3H, s, H-24), 0.91 3H, s, H-26) , 1.08 (3H, s, H-30), 1.26 (1H, m, H a -19), 1.50 (3H, s, H-27), 1.71 (3H, s, Ang (3H, s, Ac), 1.91 (3H, d, J = 7.6 Hz, Ang-H-4), 1.93 , 2.50 (1H, t, J = 14.0, H b -19), 2.78 (1H, dd, J = 14.4, 4.0 Hz, H-18), 3.14 (1H, d, J = 10.8 Hz, H a -28 ), 3.26 (1H, d, J = 10.8 Hz, H a -23), 3.39 (1H, d, J = 10.0 Hz, H b -28), 3.60 (1H, d, J = 10.8 Hz, H b - H, 1), 5.18 (1H, d, J = 4.4 Hz, H), 3.63 (1H, m, H-3), 4.50 (2H, d, J = 7.2Hz, GlcA- -15), 5.28 (1H, d , J = 4.0 Hz, H-16), 5.38 (1H, d, J = 10.8 Hz, H-21), 5.60 (1H, brs, H-12), 5.61 (1H , d, J = 10.8 Hz, H-22), 6.08 (1H, q, J = 7.6 Hz, Ang-H-3); HR-TOF-ESI-MS: m / z = 1039.5142 [M + H] + (calcd. For C 52 H 78 O 21 + H: 1039.5114).
차나무 뿌리 유래 사포닌 R3: 백색 고체; 녹는점 233 - 234℃; [α] 20 D : -28.84 (c 0.208, MeOH); IR (neat): νmax = 3415, 1726, 1368, 1249, 1023 cm-1; 1H-NMR (400 MHz, CD3OD): δ = 0.70 (3H, s, H-24), 0.91 (3H, s, H-29), 0.95 (3H, s, H-26), 1.01 (3H, s, H-25), 1.08 (3H, s, H-30), 1.35 (3H, s, H-27), 1.50 (1H, m, Ha-15), 1.74 (3H, s, Ang-H-4), 1.80 (1H, m, Hb-15), 1.90 (3H, s, Ac), 1.93 (3H, d, J = 7.6 Hz , Ang-H-5), 2.20 (3H, s, Ac), 2.66 (1H, dd, J = 14.4, 4.8 Hz, H-18), 3.10 (1H, d, J = 10.8 Hz, Ha-28), 3.27 (1H, d, J = 10.8 Hz, Ha-23), 3.29 (1H, d, J = 10.8 Hz, Hb-28), 3.60 (1H, d, J = 10.8 Hz, Hb-23), 3.64 (1H, m, H-3), 4.51 (2H, d, J = 7.2 Hz, GlcA-H-1, Ara-H-1), 5.10 (1H, brs, H-16), 5.46 (1H, brs, H-12), 5.50 (1H, d, J = 10.4 Hz, H-21), 5.58 (1H, d, J = 10.4 Hz, H-22), 6.08 (1H, q, J = 7.6 Hz, Ang-H-3); HR-TOF-ESI-MS: m/z = 981.5094 [M + H]+ (calcd. for C50H76O19 + H: 981.5059).
Saponin derived from tea root root R3: white solid; Melting point 233 - 234 ° C; [α] 20 D: -28.84 ( c 0.208, MeOH); IR (neat):? Max = 3415, 1726, 1368, 1249, 1023 cm -1 ; 1 H-NMR (400 MHz, CD 3 OD): δ = 0.70 (3H, s, H-24), 0.91 (3H, s, H-29), 0.95 (3H, s, H-26), 1.01 ( 3H, s, H-25) , 1.08 (3H, s, H-30), 1.35 (3H, s, H-27), 1.50 (1H, m, H a -15), 1.74 (3H, s, Ang -H-4), 1.80 (1H , m, H b -15), 1.90 (3H, s, Ac), 1.93 (3H, d, J = 7.6 Hz, Ang-H-5), 2.20 (3H, s , Ac), 2.66 (1H, dd, J = 14.4, 4.8 Hz, H-18), 3.10 (1H, d, J = 10.8 Hz, H a -28), 3.27 (1H, d, J = 10.8 Hz, H a -23), 3.29 (1H , d, J = 10.8 Hz, H b -28), 3.60 (1H, d, J = 10.8 Hz, H b -23), 3.64 (1H, m, H-3) , 4.51 (2H, d, J = 7.2 Hz, GlcA-H-1, Ara-H-1), 5.10 (1H, brs, H-16), 5.46 d, J = 10.4 Hz, H-21), 5.58 (1H, d, J = 10.4 Hz, H-22), 6.08 (1H, q, J = 7.6 Hz, Ang-H-3); HR-TOF-ESI-MS: m / z = 981.5094 [M + H] + (calcd for C 50 H 76 O 19 + H: 981.5059).
차나무 뿌리 유래 사포닌 R4: 백색 고체; 녹는점 227 - 228℃; [α] 20 D : -12.56 (c 0.565, MeOH); IR (neat): νmax = 3421, 1718, 1370, 1257, 1041 cm-1; 1H-NMR (400 MHz, CD3OD): δ = 0.71 (3H, s, H-24), 0.88 (3H, s, H-29), 0.86 (3H, t, J = 8.4 Hz, 2MB-H-4), 0.98 (3H, d, J = 6.8 Hz, 2MB-H-5), 1.00 (3H, s, H-26), 1.02 (3H, s, H-25), 1.07 (3H, s, H-30), 1.38 (3H, s, H-27), 1.40 (1H, m, 2MB-Ha-3), 1.58 (1H, m, 2MB-Hb-3), 1.82 (3H, s, Ang-H-5), 1.96 (3H, d, J = 7.2 Hz, Ang-H-4), 2.22 (1H, m, 2MB-H-2), 2.32 (3H, s, Ac), 2.66 (1H, dd, J = 14.0, 4.0 Hz, H-18), 3.12 (1H, d, J = 10.8 Hz, Ha-28), 3.27 (1H, overlapped with solvent, Ha-23), 3.37 (1H, d, J = 10.8 Hz, Hb-28), 3.60 (1H, d, J = 10.4 Hz, Hb-23), 3.64 (1H, m, H-3), 3.99 (1H, d, J = 4.0 Hz, H-15), 4.51 (2H, d, J = 7.2 Hz, GlcA-H-1, Ara-H-1), 5.29 (1H, d, J = 4.0 Hz, H-16), 5.41 (1H, d, J = 10.4 Hz, H-21), 5.52 (1H, brs, H-12), 5.54 (1H, d, J = 10.4 Hz, H-22), 6.15 (1H, q, J = 6.8 Hz, Ang-H-3); HR-TOF-ESI-MS: m/z = 1039.5471 [M + H]+ (calcd. for C53H82O20 + H: 1039.5478).
Saponin derived from root of tea root R4: white solid; Melting point 227 - 228 ° C; [α] 20 D: -12.56 ( c 0.565, MeOH); IR (neat):? Max = 3421, 1718, 1370, 1257, 1041 cm -1 ; 1 H-NMR (400 MHz, CD 3 OD): δ = 0.71 (3H, s, H-24), 0.88 (3H, s, H-29), 0.86 (3H, t, J = 8.4 Hz, 2MB- H-4), 0.98 (3H, d, J = 6.8 Hz, 2MB-H-5), 1.00 (3H, s, H-26), 1.02 , H-30), 1.38 ( 3H, s, H-27), 1.40 (1H, m, 2MB-H a -3), 1.58 (1H, m, 2MB-H b -3), 1.82 (3H, s (AngH-5), 1.96 (3H, d, J = 7.2 Hz, Ang-H-4), 2.22 1H, dd, J = 14.0, 4.0 Hz, H-18), 3.12 (1H, d, J = 10.8 Hz, H a -28), 3.27 (1H, overlapped with solvent, H a -23), 3.37 (1H , d, J = 10.8 Hz, H b -28), 3.60 (1H, d, J = 10.4 Hz, H b -23), 3.64 (1H, m, H-3), 3.99 (1H, d, J = 4.0 Hz, H-15), 4.51 (2H, d, J = 7.2 Hz, GlcA-H-1, Ara-H-1), 5.29 (1H, d, J = 4.0 Hz, H-16), 5.41 ( 1H, d, J = 10.4 Hz , H-21), 5.52 (1H, brs, H-12), 5.54 (1H, d, J = 10.4 Hz, H-22), 6.15 (1H, q, J = 6.8 Hz, Ang-H-3); HR-TOF-ESI-MS: m / z = 1039.5471 [M + H] + (calcd. For C 53 H 82 O 20 + H: 1039.5478).
차나무 뿌리 유래 사포닌 R5: 백색 고체; 녹는점 231 - 232℃; [α] 20 D : + 4.35 (c 0.46, MeOH); IR (neat): νmax = 3395, 1711, 1442, 1256, 1039 cm-1; 1H-NMR (400 MHz, CD3OD): δ = 0.85 (3H, s, H-29), 0.88 (3H, t, J = 7.2 Hz, 2MB-H-4), 1.01 (3H, s, H-25), 1.02 (3H, d, J = 6.0 Hz , 2MB-H-5), 1.04 (3H, s, H-26), 1.07 (3H, s, H-30), 1.13 (3H, s, H-24), 1.42 (1H, m, 2MB-Ha-3), 1.44 (3H, s, H-27), 1.60 (1H, m, 2MB-Hb-3), 1.85 (3H, s, Ang-H-5), 1.98 (3H, d, J = 6.8 Hz, Ang-H-4), 2.32 (1H, m, 2MB-H-2), 2.62 (1H, dd, J = 14.0, 4.0 Hz, H-18), 3.00 (1H, d, J = 10.4 Hz, Ha-28), 3.27 (1H, d, J = 10.8 Hz, Hb-28), 3.71 (1H, d, J = 4.0 Hz, H-15), 3.79 (1H, d, J = 4.8 Hz, H-16), 3.89 (1H, m, H-3), 4.32 (1H, d, J = 7.6 Hz, GlcA-H-1), 4.50 (1H , d, J = 6.4 Hz, Ara-H-1), 5.47 (1H, brs, H-12), 5.55 (1H, d, J = 10.4 Hz, H-22), 5.86 (1H, d, J = 10.4 Hz, H-21), 6.14 (1H, q, J = 7.2 Hz, Ang-H-3), 9.41 (1H, s, H-23); HR-TOF-ESI-MS: m/z = 995.5282 [M + H]+ (calcd. for C51H78O19 + H: 995.5216).
Saponin derived from root of tea root R5: white solid; Melting point 231 - 232 ℃; [α] 20 D: + 4.35 (c 0.46, MeOH); IR (neat):? Max = 3395, 1711, 1442, 1256, 1039 cm -1 ; 1 H-NMR (400 MHz, CD 3 OD):? = 0.85 (3H, s, H-29), 0.88 (3H, t, J = 7.2 Hz, 2MB- H-25), 1.02 (3H, d, J = 6.0 Hz, 2MB-H-5), 1.04 (3H, s, , H-24), 1.42 ( 1H, m, 2MB-H a -3), 1.44 (3H, s, H-27), 1.60 (1H, m, 2MB-H b -3), 1.85 (3H, s , Ang-H-5), 1.98 (3H, d, J = 6.8 Hz, Ang-H-4), 2.32 (1H, m, 2MB-H-2), 2.62 (1H, dd, J = 14.0, 4.0 Hz, H-18), 3.00 (1H, d, J = 10.4 Hz, H a -28), 3.27 (1H, d, J = 10.8 Hz, H b -28), 3.71 (1H, d, J = 4.0 Hz, H-15), 3.79 (1H, d, J = 4.8 Hz, H-16), 3.89 (1H, m, H-3), 4.32 (1H, d, J = 7.6 Hz, GlcA-H-1 ), 4.50 (1H, d, J = 6.4 Hz, Ara-H-1), 5.47 (1H, brs, H-12), 5.55 (1H, d, J = 10.4 Hz, H-22), 5.86 (1H , d, J = 10.4 Hz, H-21), 6.14 (1H, q, J = 7.2 Hz, Ang-H-3), 9.41 (1H, s, H-23); HR-TOF-ESI-MS: m / z = 995.5282 [M + H] + (calcd for C 51 H 78 O 19 + H:. 995.5216).
차나무 뿌리 유래 사포닌 R6: 백색 고체; 녹는점 229 - 230℃; [α] 20 D : -9.56 (c 0.23, MeOH); IR (neat): νmax = 3424, 1728, 1538, 1456, 1229, 1070 cm-1; 1H-NMR (400 MHz, CD3OD): δ = 0.86 (3H, t, J = 6.4 Hz, 2MB-H-4), 0.92 (3H, s, H-29), 0.99 (3H, d, J = 7.2 Hz , 2MB-H-5), 1.02 (3H, s, H-25), 1.04 (3H, s, H-26), 1.07 (3H, s, H-30), 1.10 (3H, s, H-24), 1.36 (H, dd, J = 13.6, 4.0 Hz, 2MB-Ha-3), 1.57 (1H, dd, J = 13.6, 7.2 Hz, 2MB-Hb-3), 1.39 (3H, s, H-27), 1.84 (3H, s, Ang-H-5), 1.97 (3H, d, J = 7.2 Hz , Ang-H-4), 2.24 (1H, m, 2MB-H-2), 2.32 (3H, s, Ac), 2.64 (1H, dd, J = 14.4, 4.0 Hz, H-18), 3.12 (1H, d, J = 10.8 Hz, Ha-28), 3.34 (1H, d, J = 10.8 Hz, Hb-28), 3.90 (1H, dd, J = 8.8 & 2.8 Hz, H-3), 3.97 (1H, d, J = 4.8 Hz, H-15), 4.33 (1H, d, J = 7.6 Hz, GlcA-H-1), 4.49 (1H , d, J = 6.8 Hz, Ara-H-1), 5.28 (1H, d, J = 4.4 Hz, H-16), 5.41 (1H, d, J = 10.4 Hz, H-21), 5.54 (1H, d, J = 10.4 Hz, H-22), 5.55 (1H, brs, H-12), 6.16 (1H, q, J = 7.2 Hz, Ang-H-3), 9.40 (1H, s, H-23); HR-TOF-ESI-MS: m/z = 1037.5406 [M + H]+ (calcd. for C53H80O20 + H: 1037.5321).
Saponin derived from root of tea root R6: white solid; Melting point 229 - 230 캜; [?] 20 D : -9.56 ( c 0.23, MeOH); IR (neat):? Max = 3424, 1728, 1538, 1456, 1229, 1070 cm -1 ; 1 H-NMR (400 MHz, CD 3 OD): δ = 0.86 (3H, t, J = 6.4 Hz, 2MB-H-4), 0.92 (3H, s, H-29), 0.99 (3H, d, J = 7.2 Hz, 2MB-H -5), 1.02 (3H, s, H-25), 1.04 (3H, s, H-26), 1.07 (3H, s, H-30), 1.10 (3H, s , H-24), 1.36 ( H, dd, J = 13.6, 4.0 Hz, 2MB-H a -3), 1.57 (1H, dd, J = 13.6, 7.2 Hz, 2MB-H b -3), 1.39 ( 3H, s, H-27) , 1.84 (3H, s, Ang-H-5), 1.97 (3H, d, J = 7.2 Hz, Ang-H-4), 2.24 (1H, m, 2MB-H- 2), 2.32 (3H, s , Ac), 2.64 (1H, dd, J = 14.4, 4.0 Hz, H-18), 3.12 (1H, d, J = 10.8 Hz, H a -28), 3.34 (1H (d, J = 10.8 Hz, H b -28), 3.90 (1H, dd, J = 8.8 and 2.8 Hz, H-3), 3.97 (1H, d, J = 4.8 Hz, 1H, d, J = 7.6 Hz , GlcA-H-1), 4.49 (1H, d, J = 6.8 Hz, Ara-H-1), 5.28 (1H, d, J = 4.4 Hz, H-16), 5.41 (1H, d, J = 10.4 Hz, H-21), 5.54 (1H, d, J = 10.4 Hz, H-22), 5.55 (1H, brs, H-12), 6.16 (1H, q, J = 7.2 Hz, Ang-H-3), 9.40 (1H, s, H-23); HR-TOF-ESI-MS: m / z = 1037.5406 [M + H] + (calcd. For C 53 H 80 O 20 + H: 1037.5321).
차나무 뿌리 유래 사포닌 R7: 백색 고체; 녹는점 223 - 224℃; [α] 20 D : -13.01 (c 0.315, MeOH); IR (neat): νmax = 3407, 1714, 1370, 1249, 1039 cm-1; 1H-NMR (400 MHz, CD3OD): δ = 0.86 (3H, t, J = 7.4 Hz, 2MB-H-4), 0.89 (3H, s, H-29), 0.98 (3H, s, H-25), 0.99 (3H, d, J = 7.2 Hz , 2MB-H-5), 1.00 (3H, s, H-26), 1.07 (3H, s, H-30), 1.16 (3H, s, H-24), 1.37 (3H, s, H-27), 1.38 (1H, m, 2MB-Ha-3), 1.56 (1H, m, 2MB-Hb-3), 1.82 (3H, s, Ang-H-5), 1.97 (3H, d, J = 7.2 Hz, Ang-H-4), 2.26 (1H, m, 2MB-H-2), 2.31 (3H, s, Ac), 2.66 (1H, dd, J = 14.8, 4.0 Hz, H-18), 3.12 (1H, d, J = 10.8 Hz, Ha-28), 3.34 (1H, d, J = 10.8 Hz, Hb-28), 3.68 (3H, s, 23-COOCH 3 ), 3.96 (1H, d, J = 4.8 Hz, H-15), 4.03 (1H, dd, J = 11.6, 4.4 Hz, H-3), 4.30 (1H, d, J = 8.0 Hz, GlcA-H-1), 4.50 (1H , d, J = 6.8 Hz, Ara-H-1), 5.28 (1H, d, J = 4.4 Hz, H-16), 5.41 (1H, d, J = 10.4 Hz, H-21), 5.54 (1H, brs, H-12), 5.54 (1H, d, J = 10.8 Hz, H-22), 6.16 (1H, q, J = 7.0 Hz, Ang-H-3); HR-TOF-ESI-MS: m/z = 1067.5492 [M + H]+ (calcd. for C54H82O21 + H: 1067.5427).
Saponin derived from root of tea root R7: white solid; Melting point 223 - 224 ° C; [?] 20 D : -13.01 ( c 0.315, MeOH); IR (neat):? Max = 3407, 1714, 1370, 1249, 1039 cm -1 ; 1 H-NMR (400 MHz, CD 3 OD): δ = 0.86 (3H, t, J = 7.4 Hz, 2MB-H-4), 0.89 (3H, s, H-29), 0.98 (3H, s, (3H, s, H-25), 0.99 (3H, d, J = 7.2 Hz, 2MB-H-5), 1.00 , H-24), 1.37 ( 3H, s, H-27), 1.38 (1H, m, 2MB-H a -3), 1.56 (1H, m, 2MB-H b -3), 1.82 (3H, s H-5), 1.97 (3H, d, J = 7.2 Hz, Ang-H-4), 2.26 1H, dd, J = 14.8, 4.0 Hz, H-18), 3.12 (1H, d, J = 10.8 Hz, H a -28), 3.34 (1H, d, J = 10.8 Hz, H b -28), 3.68 (3H, s, 23- COOC H 3), 3.96 (1H, d, J = 4.8 Hz, H-15), 4.03 (1H, dd, J = 11.6, 4.4 Hz, H-3), 4.30 (1H , d, J = 8.0 Hz, GlcA-H-1), 4.50 (1H, d, J = 6.8 Hz, Ara-H-1), 5.28 (1H, d, J = 4.4 Hz, H-16), 5.41 (1H, d, J = 10.4 Hz, H-21), 5.54 (1H, brs, H-12), 5.54 (1H, d, J = 10.8 Hz, H-22), 6.16 (1H, q, J = 7.0 Hz, Ang-H-3); HR-TOF-ESI-MS: m / z = 1067.5492 [M + H] + (calcd. For C 54 H 82 O 21 + H: 1067.5427).
차나무 뿌리 유래 사포닌 R8: 백색 고체; 녹는점 231 - 232℃; [α] 20 D : -8.62 (c 0.105, MeOH); IR (neat): νmax = 3411, 1722, 1441, 1242, 1073 cm-1; 1H-NMR (400 MHz, CD3OD): δ = 0.84 (3H, s, H-29), 0.85 (3H, s, H-24), 0.88 (3H, t, J = 7.2 Hz, 2MB-H-4), 0.98 (3H, s, H-25), 1.01 (3H, s, H-26), 1.02 (3H, d, J = 7.2 Hz , 2MB-H-5), 1.05 (3H, s, H-23), 1.07 (3H, s, H-30), 1.41 (3H, s, H-27), 1.42 (1H, m, 2MB-Ha-3), 1.60 (H, m, 2MB-Hb-3), 1.84 (3H, s, Ang-H-5), 1.98 (3H, d, J = 7.2 Hz, Ang-H-5), 2.30 (1H, m, 2MB-H-2), 2.62 (1H, m, H-18), 2.99 (1H, d, J = 10.0 Hz, Ha-28), 3.18 (1H, dd, J = 9.2, 5.2 Hz, H-3), 3.30 (1H, overlapped with solvent, Hb-28), 3.73 (1H, d, J = 4.0 Hz, H-15), 3.80 (1H, d, J = 4.0 Hz, H-16), 4.41 (1H, d, J = 7.2 Hz, GlcA-H-1), 4.53 (1H , d, J = 6.8 Hz, Ara-H-1), 5.47 (1H, brs, H-12), 5.55 (1H, d, J = 10.0 Hz, H-22), 5.86 (1H, d, J = 10.0 Hz, H-21), 6.16 (1H, q, J = 7.2 Hz, Ang-H-3); HR-TOF-ESI-MS: m/z = 981.5435 [M + H]+ (calcd. for C51H80O18 + H: 981.5423).
Saponin derived from tea root root R8: white solid; Melting point 231 - 232 ℃; [α] 20 D: -8.62 ( c 0.105, MeOH); IR (neat):? Max = 3411, 1722, 1441, 1242, 1073 cm -1 ; 1 H-NMR (400 MHz, CD 3 OD): δ = 0.84 (3H, s, H-29), 0.85 (3H, s, H-24), 0.88 (3H, t, J = 7.2 Hz, 2MB- H-4), 0.98 (3H , s, H-25), 1.01 (3H, s, H-26), 1.02 (3H, d, J = 7.2 Hz, 2MB-H-5), 1.05 (3H, s , H-23), 1.07 ( 3H, s, H-30), 1.41 (3H, s, H-27), 1.42 (1H, m, 2MB-H a -3), 1.60 (H, m, 2MB- H b -3), 1.84 (3H , s, Ang-H-5), 1.98 (3H, d, J = 7.2 Hz, Ang-H-5), 2.30 (1H, m, 2MB-H-2), 2.62 (1H, m, H- 18), 2.99 (1H, d, J = 10.0 Hz, H a -28), 3.18 (1H, dd, J = 9.2, 5.2 Hz, H-3), 3.30 (1H, overlapped with solvent, H b -28) , 3.73 (1H, d, J = 4.0 Hz, H-15), 3.80 (1H, d, J = 4.0 Hz, H-16), 4.41 (1H, d, J = (1H, d, J = 10.0 Hz, 1H), 4.53 (1H, d, J = 7.2 Hz, GlcA-H- H-22), 5.86 (1H, d, J = 10.0 Hz, H-21), 6.16 (1H, q, J = 7.2 Hz, Ang-H-3); HR-TOF-ESI-MS: m / z = 981.5435 [M + H] + (calcd for C 51 H 80 O 18 + H:. 981.5423).
차나무 뿌리 유래 사포닌 R9: 백색 고체; 녹는점 232 - 233℃; [α] 20 D : -24.15 (c 0.31, MeOH); IR (neat): νmax = 3443, 1724, 1459, 1234, 1072 cm-1; 1H-NMR (400 MHz, CD3OD): δ = 0.71 (3H, s, H-24), 0.84 (3H, t, J = 7.2 Hz, 2MB-H-4), 0.88 (3H, s, H-29), 0.95 (3H, s, H-26), 0.98 (3H, d, J = 6.8 Hz , 2MB-H-5), 1.01 (3H, s, H-25), 1.09 (3H, s, H-30), 1.32 (1H, m, 2MB-Ha-3), 1.37 (3H, s, H-27), 1.44 (1H, m, Ha-15), 1.57 (H, m, 2MB-Hb-3), 1.80 (1H, m, Hb-15), 1.83 (3H, s, Ang-H-5), 1.97 (3H, d, J = 7.2 Hz, Ang-H-4), 2.20 (1H, m, 2MB-H-2), 2.27 (3H, s, Ac), 2.66 (1H, dd, J = 14.0, 3.6 Hz, H-18), 3.08 (1H, d, J = 10.4 Hz, Ha-28), 3.29 (1H, overlapped with solvent, Ha-23), 3.32 (1H, overlapped with solvent, Hb-28), 3.60 (1H, d, J = 10.0 Hz, Hb-23), 3.63 (1H, m, H-3), 4.51 (2H, d, J = 7.2 Hz, GlcA-H-1, Ara-H-1), 5.15 (1H, brs, H-16), 5.45 (1H, brs, H-12), 5.54 (2H, s, H-21 and H-22), 6.16 (1H, q, J = 7.6 Hz, Ang-H-3); HR-TOF-ESI-MS: m/z = 1023.5556 [M + H]+ (calcd. for C53H82O19 + H: 1023.5529).
Saponin derived from root of tea root R9: white solid; Melting point 232 - 233 ° C; [?] 20 D : -24.15 ( c 0.31, MeOH); IR (neat):? Max = 3443, 1724, 1459, 1234, 1072 cm -1 ; 1 H-NMR (400 MHz, CD 3 OD): δ = 0.71 (3H, s, H-24), 0.84 (3H, t, J = 7.2 Hz, 2MB-H-4), 0.88 (3H, s, H-29), 0.95 (3H, s, H-26), 0.98 (3H, d, J = 6.8 Hz, 2MB-H-5), 1.01 , H-30), 1.32 ( 1H, m, 2MB-H a -3), 1.37 (3H, s, H-27), 1.44 (1H, m, H a -15), 1.57 (H, m, 2MB -H b -3), 1.80 (1H , m, H b -15), 1.83 (3H, s, Ang-H-5), 1.97 (3H, d, J = 7.2 Hz, Ang-H-4), 2.20 (1H, m, 2MB- H-2), 2.27 (3H, s, Ac), 2.66 (1H, dd, J = 14.0, 3.6 Hz, H-18), 3.08 (1H, d, J = 10.4 Hz , H a -28), 3.29 ( 1H, overlapped with solvent, H a -23), 3.32 (1H, overlapped with solvent, H b -28), 3.60 (1H, d, J = 10.0 Hz, H b -23 ), 3.63 (1H, m, H-3), 4.51 (2H, d, J = 7.2 Hz, GlcA-H-1, Ara- 1H, brs, H-12), 5.54 (2H, s, H-21 and H-22), 6.16 (1H, q, J = 7.6 Hz, Ang-H-3); HR-TOF-ESI-MS: m / z = 1023.5556 [M + H] + (calcd. For C 53 H 82 O 19 + H: 1023.5529).
차나무 뿌리 유래 사포닌 R10: 백색 고체; 녹는점 232 - 233℃; [α] 20 D : -22.06 (c 0.29, MeOH); IR (neat): νmax = 3433, 1720, 1458, 1229, 1072 cm-1; 1H-NMR (400 MHz, CD3OD): δ = 0.70 (3H, s, H-24), 0.85 (3H, t, J = 7.6 Hz, 2MB-H-4), 0.89 (3H, s, H-29), 0.95 (3H, s, H-26), 0.98 (3H, d, J = 6.8 Hz , 2MB-H-5), 1.01 (3H, s, H-25), 1.09 (3H, s, H-30), 1.36 (3H, s, H-27), 1.37 (1H, m, 2MB-Ha-3), 1.43 (1H, m, Ha -15), 1.55 (1H, m, 2MB-Hb-3), 1.81 (1H, m, Hb-15), 1.83 (3H, s, Ang-H-5), 1.96 (3H, d, J = 7.2 Hz, Ang-H-4), 2.22 (1H, m, 2MB-H-2), 2.27 (3H, s, Ac), 2.66 (1H, dd, J = 14.0, 4.0 Hz, H-18), 3.08 (1H, d, J = 10.8 Hz, Ha-28), 3.29 (1H, overlapped with solvent, Ha-23), 3.32 (1H, overlapped with solvent, Hb-28), 3.60 (1H, d, J = 10.8 Hz, Hb-23), 3.62 (1H, m, H-3), 3.77 (3H, s, GlcA-6-OCH 3 ), 4.51 (2H, d, J = 7.2 Hz, GlcA-H-1, Ara-H-1), 5.16 (1H, brs, H-16), 5.46 (1H, brs, H-12), 5.54 (2H, s, H-21 and H-22), 6.16 (1H, q, J = 7.0 Hz, Ang-H-3); HR-TOF-ESI-MS: m/z = 1037.5684 [M + H]+ (calcd. for C54H84O19 + H: 1037.5685).
Saponin derived from root of tea root R10: white solid; Melting point 232 - 233 ° C; [?] 20 D : -22.06 ( c 0.29, MeOH); IR (neat):? Max = 3433, 1720, 1458, 1229, 1072 cm -1 ; 1 H-NMR (400 MHz, CD 3 OD): δ = 0.70 (3H, s, H-24), 0.85 (3H, t, J = 7.6 Hz, 2MB-H-4), 0.89 (3H, s, H-29), 0.95 (3H, s, H-26), 0.98 (3H, d, J = 6.8 Hz, 2MB-H-5), 1.01 , H-30), 1.36 ( 3H, s, H-27), 1.37 (1H, m, 2MB-H a -3), 1.43 (1H, m, H a -15), 1.55 (1H, m, 2MB -H b -3), 1.81 (1H , m, H b -15), 1.83 (3H, s, Ang-H-5), 1.96 (3H, d, J = 7.2 Hz, Ang-H-4), 2.22 (1H, m, 2MB- H-2), 2.27 (3H, s, Ac), 2.66 (1H, dd, J = 14.0, 4.0 Hz, H-18), 3.08 (1H, d, J = 10.8 Hz , H a -28), 3.29 ( 1H, overlapped with solvent, H a -23), 3.32 (1H, overlapped with solvent, H b -28), 3.60 (1H, d, J = 10.8 Hz, H b -23 ), 3.62 (1H, m, H-3), 3.77 (3H, s, GlcA-6-OC H 3), 4.51 (2H, d, J = 7.2 Hz, GlcA-H-1, Ara-H-1 ), 5.16 (1H, brs, H-16), 5.46 (1H, brs, H-12), 5.54 (2H, s, H-21 and H-22), 6.16 (1H, q, J = 7.0 Hz, Ang-H-3); HR-TOF-ESI-MS: m / z = 1037.5684 [M + H] + (calcd. For C 54 H 84 O 19 + H: 1037.5685).
[실시예 1∼2 및 비교예 1] 치약 조성물의 제조 [Examples 1 to 2 and Comparative Example 1] Preparation of dentifrice composition
하기 표 1과 같은 성분을 주성분으로 하여 본 발명의 치약 조성물(실시예 1∼2) 및 통상적인 치약 조성물(비교예 1)을 제조하였다.The dentifrice compositions of the present invention (Examples 1 to 2) and the conventional dentifrice composition (Comparative Example 1) were prepared using the components as shown in Table 1 as the main components.
[시험예 1] 치면 세균막 지수 비교 시험[Test Example 1] Comparison test of tooth surface bacterial film index
본 실험은 비교적 동일한 환경에 있는 피검자 120명을 대상으로 실시하였으며, 피검자 전원이 실험 전 1차 구강정밀검사를 실시하여 기준선(base line)을 구하였다. 단일 맹검법을 적용하였고 실험 전 4주 동안의 잔류효과 제거기간 동안 피검자 전원에게 동일 세치제 및 동일규격의 칫솔을 제공하였다. 2개월 간격으로 총 3차례 측정하였으며 검사방법은 치면 착색액 10방울에 물 20ml를 혼합하여 입안에서 1분간 머금은 뒤 뱉어내고 물로 가볍게 양치한 후 착색상태를 Quigley & Hein의 Turesky modification 기준을 적용하였으며, 그 결과를 하기 표 2에 나타내었다. This study was conducted on 120 subjects who were in the same environment, and all of the subjects performed a first oral examination before the experiment to obtain a base line. A single blind method was applied and all subjects were given the same toothbrushes and toothbrushes of the same size during the period of eliminating the residual effect for 4 weeks before the experiment. The test method was as follows: 10 drops of dyestuff coloring solution was mixed with 20 ml of water, and the mixture was spit out for 1 minute in the mouth. After lightly brushing with water, the coloring state was applied by Quigley & Hein's Turesky modification standard, The results are shown in Table 2 below.
mean±S.D.base line
mean ± SD
mean±S.D.Two months later
mean ± SD
mean±S.D.After 5 months
mean ± SD
(by ANOVA)P value
(by ANOVA)
처음 2개월 후 1차 정밀구강검사 결과, 치면세균막 지수에서 비교예 1은 2.6%의 증가를 보였지만 실시예 1 및 실시예 2는 각각 15.6% 및 28.9%의 감소를 나타냈다. 5개월 후의 2차 정밀구강검사 결과에서는 비교예 1은 2.6%의 감소를, 실시예 1 및 실시예 2는 각각 20.8% 및 40.8%의 치면세균막 지수의 감소를 나타내었다 (도 1). As a result of the first precision oral examination after the first two months, Comparative Example 1 showed an increase of 2.6% in the dental bacterial membrane index, whereas Example 1 and Example 2 showed a decrease of 15.6% and 28.9%, respectively. In the result of the second precision oral examination after 5 months, Comparative Example 1 showed a decrease of 2.6%, and Example 1 and Example 2 showed a decrease of the tooth surface bacteria index of 20.8% and 40.8%, respectively (Fig.
상기 결과에서 실시예 1 및 실시예 2가 비교예 1에 비해 모두 유의한 수준으로 치면세균막이 감소함을 보였다.
From the above results, it was shown that the bacterial membranes were decreased when the levels of both Example 1 and Example 2 were significantly higher than those of Comparative Example 1.
[시험예 2] 치은염지수 비교 시험[Test Example 2] Comparison test of gingival index
본 실험은 비교적 동일한 환경에 있는 피검자 120명을 대상으로 실시하였으며, 피검자 전원이 실험 전 1차 구강정밀검사를 실시하여 기준선을 구하였다. 단일 맹검법을 적용하였고, 실험 전 4주 동안의 잔류효과 제거기간 동안 피검자 전원에게 동일 세치제 및 동일규격의 칫솔을 제공하였다. 2개월 간격으로 총 3차례 측정하였으며 실험 방법은 한 개의 치아 당 치은을 협면과 설면으로 구획한 후 산출된 지수의 평균값으로 산출하였다. 각 치은염은 Loe & Silness의 평점 기준에 따라 0점부터 3점까지로 평가하여 치아별 치은염 지수를 구한 뒤 평균성적으로 개체의 치은염 지수를 산출하였으며, 그 결과를 하기 표 3에 나타내었다.This study was conducted on 120 subjects who were in the same environment. The baseline was obtained by conducting a first oral examination before the experiment. A single blind method was applied, and all subjects were given the same toothbrush and toothbrush of the same size during the period of eliminating residual effect for 4 weeks before the experiment. The gingiva was divided into two groups: the gingival perforation and the lingual surface, and the average value of the index was calculated. Each gingivitis was graded from 0 to 3 according to the criteria of Loe & Silness, and the gingivitis index of each tooth was obtained. The gingival index of the individual was calculated by the average score. The results are shown in Table 3 below.
mean±S.D.base line
mean ± SD
mean±S.D.Two months later
mean ± SD
mean±S.D.After 5 months
mean ± SD
(by ANOVA)P value
(by ANOVA)
처음 2개월 후인 1차 정밀구강검사 결과에서 치은염지수는 비교예 1이 8.1% 감소를 보였지만, 실시예 1 및 실시예 2는 각각 33.8% 및 20.0% 감소를 나타내었다. 5개월 후의 2차 정밀구강검사 결과에서는 비교예 1이 9% 감소를 나타내었으며, 실시예 1 및 실시예 2는 각각 30.8%와 31.7%의 감소를 나타내었다 (도 2). In the first two months after the first precision oral examination, the gingivitis index of Comparative Example 1 decreased by 8.1%, while that of Example 1 and Example 2 decreased by 33.8% and 20.0%, respectively. In the second precision oral examination after 5 months, Comparative Example 1 showed a decrease of 9%, and Example 1 and Example 2 showed a decrease of 30.8% and 31.7%, respectively (Fig. 2).
상기 결과로부터 실시예 1 및 실시예 2가 비교예 1에 비해 모두 유의한 수준으로 치은염지수가 감소함을 보였다.
From the above results, it was shown that the gingival indexes of Example 1 and Example 2 were significantly lower than those of Comparative Example 1, respectively.
[시험예 3] 구취농도지수[Test Example 3]
본 실험은 비교적 동일한 환경에 있는 피검자 120명을 대상으로 실시하였으며, 피검자 전원이 실험 전 1차 구강정밀검사를 실시하여 기준선을 구하였다. 단일 맹검법을 적용하였고, 실험 전 4주 동안의 잔류효과 제거기간 동안 피검자 전원에게 동일 세치제 및 동일규격의 칫솔을 제공하였다. 2개월 간격으로 총 3차례 측정하였으며, 측정방법은 측정 전 3분간 입을 다물게 한 후 Halimeter(model RH-17(Interscan co, U.S.A)에 스트로우를 연결하고 0±5ppb로 영점 세팅한 후 기기 제조사가 지정하는 소정의 방법에 따라 측정하였으며, 그 결과를 하기 표 4에 나타내었다.This study was conducted on 120 subjects who were in the same environment. The baseline was obtained by conducting a first oral examination before the experiment. A single blind method was applied, and all subjects were given the same toothbrush and toothbrush of the same size during the period of eliminating residual effect for 4 weeks before the experiment. The measurements were made 3 times at 2-month intervals. The measurement was done for 3 minutes before measurement. After the mouth was closed, the straw was connected to a Halimeter (Model RH-17 (Interscan co, USA) The results are shown in Table 4 below.
mean±S.D.base line
mean ± SD
mean±S.DTwo months later
mean ± SD
mean±S.D.After 5 months
mean ± SD
(by ANOVA)P value
(by ANOVA)
처음 2개월 후 1차 정밀구강검사 결과에서 구취농도지수는 비교예 1이 0.8% 감소를 보였고, 실시예 1 및 실시예 2가 각각 10.7% 및 17.7% 감소를 나타내었다. 5개월 후 2차 정밀구강검사 결과에서 비교예 1은 1.6% 증가, 실시예 1과 실시예 2는 각각 14.9% 및 25.0% 감소를 나타내었다 (도 3). In the first two months after the first oral oral test, the odor concentration index of Comparative Example 1 showed a decrease of 0.8%, and that of Example 1 and Example 2 decreased by 10.7% and 17.7%, respectively. After 5 months, the results of the second precision oral test showed that Comparative Example 1 increased by 1.6% and Example 1 and Example 2 decreased by 14.9% and 25.0%, respectively (Fig. 3).
상기 결과에서 실시예 1과 실시예 2가 비교예 1에 비해 모두 유의한 수준으로 치은염지수가 감소함을 보였다.
The results showed that the gingival indexes of Examples 1 and 2 were significantly lower than those of Comparative Example 1, respectively.
상기에서 살펴본 바와 같이, 본 발명에 따른 구강용 조성물은 치은염지수의 감소 및 구취농도 지수의 유효한 수치의 감소로 판단했을 때 치은염 및 치주염 등의 치주질환 개선 효과 및 구취 억제 효과가 우수하였다.
As described above, the oral composition according to the present invention has excellent gingivitis and periodontal disease improving effect and bad breath suppressing effect when it is considered that the gingival index is decreased and the effective value of the bad breath index is decreased.
본 발명에 의한 구강용 조성물은 하기의 제형예와 같이 제조될 수 있으나, 이에 한정되는 것은 아니다.
The composition for oral use according to the present invention can be prepared as in the following formulation examples, but is not limited thereto.
[제형예 1] 치약[Formulation Example 1] Toothpaste
참조예 1의 차나무 뿌리 유래 사포닌 R1-10를 총 조성물 중량의 1 내지 3중량%로 포함시키고, 향료, 감미제, 점증제, 연마제 및 치석 제거제를 적량으로 첨가한 후 정제수로 전체량을 조절하여 치약을 제조하였다.
Saponin R1-10 derived from root of Reference Example 1 was contained in an amount of 1 to 3% by weight of the total composition and the whole amount was adjusted with purified water after adding perfume, sweetener, thickeners, abrasive, .
[제형예 2] 구강 스프레이제 [Formulation Example 2] Oral spray agent
참조예 1의 차나무 뿌리 유래 사포닌 R1-10 10mg을 통상의 구강 스프레이 제조방법에 따라 정제수에 첨가하고 맛 차단제 및/또는 향미제를 총 조성물의 0.75 내지 7.5 중량%로 첨가한 후, 전체를 300ml로 조절하여 구강 스프레이제를 제조하였다.10 mg of saponin R1-10 derived from tea root root of Reference Example 1 was added to purified water according to a conventional oral spray preparation method, and 0.75 to 7.5% by weight of a total amount of a taste blocker and / or flavoring agent was added thereto. To prepare an oral spray.
Claims (6)
상기 트리테르페노이드계 사포닌은 하기 화학식 1 내지 10으로 나타내는 사포닌 중 하나 이상인, 치주 질환 예방 및 개선용 조성물.
[화학식 1]
[화학식 2]
[화학식 3]
[화학식 4]
[화학식 5]
[화학식 6]
[화학식 7]
[화학식 8]
[화학식 9]
[화학식 10]
A composition for preventing and improving periodontal disease, comprising tea root root-derived triterpenoid saponin as an active ingredient,
Wherein the triterpenoid saponin is at least one of saponins represented by the following formulas (1) to (10).
[Chemical Formula 1]
(2)
(3)
[Chemical Formula 4]
[Chemical Formula 5]
[Chemical Formula 6]
(7)
[Chemical Formula 8]
[Chemical Formula 9]
[Chemical formula 10]
상기 트리테르페노이드계 사포닌은 하기 화학식 1 내지 10으로 나타내는 사포닌 중 하나 이상인, 구취 억제용 조성물.
[화학식 1]
[화학식 2]
[화학식 3]
[화학식 4]
[화학식 5]
[화학식 6]
[화학식 7]
[화학식 8]
[화학식 9]
[화학식 10]
A composition for suppressing bad breath, comprising tea root root-derived triterpenoid saponin as an active ingredient,
Wherein the triterpenoid saponin is at least one of saponins represented by the following formulas (1) to (10).
[Chemical Formula 1]
(2)
(3)
[Chemical Formula 4]
[Chemical Formula 5]
[Chemical Formula 6]
(7)
[Chemical Formula 8]
[Chemical Formula 9]
[Chemical formula 10]
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110099525A KR101816638B1 (en) | 2011-09-30 | 2011-09-30 | Oral composition comprising saponin extracted from the root of Camellia sinensis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110099525A KR101816638B1 (en) | 2011-09-30 | 2011-09-30 | Oral composition comprising saponin extracted from the root of Camellia sinensis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20130035323A KR20130035323A (en) | 2013-04-09 |
| KR101816638B1 true KR101816638B1 (en) | 2018-01-10 |
Family
ID=48437174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020110099525A Expired - Fee Related KR101816638B1 (en) | 2011-09-30 | 2011-09-30 | Oral composition comprising saponin extracted from the root of Camellia sinensis |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR101816638B1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015172429A1 (en) * | 2014-05-12 | 2015-11-19 | 深圳市恒昇启泰进出口有限公司 | Camellia oil liquid preparation for prevention and treatment of oral diseases |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100821842B1 (en) | 2006-11-30 | 2008-04-14 | 주식회사 엘지생활건강 | Skin cosmetic composition for allergy relief and prevention |
-
2011
- 2011-09-30 KR KR1020110099525A patent/KR101816638B1/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100821842B1 (en) | 2006-11-30 | 2008-04-14 | 주식회사 엘지생활건강 | Skin cosmetic composition for allergy relief and prevention |
Non-Patent Citations (3)
| Title |
|---|
| P. Sur 외 4명. Antiinflammatory and Antioxidant Property of Saponins of Tea [Camellia sinensis (L) O. Kuntze] Root Extract. Phytother. Res. Vol. 15, 2001년, pp. 174-176 |
| Titto Varughese 외 5명. Tea Triterpenoidal Saponins from the Roots of Camellia sinensis Have Inhibitory Effects against Alcohol Dehydrogenase. Planta Med. Vol. 77, 2011년, pp. 2029-2036 |
| Yi Lu 외 6명. Triterpenoid saponins from the roots of tea plant (Camellia sinensis var. assamica ). Phytochemistry. Vol. 53, 2000년, pp. 941-946 |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20130035323A (en) | 2013-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2150233B1 (en) | Liquorice extract antimicrobial and anti-inflammatory isolates | |
| KR101354923B1 (en) | Oral hygiene composition using an extract of curcuma longa and an extract eriobotrya japonica | |
| EP0616520B1 (en) | Phytate-antimicrobial compositions in oral care products | |
| KR940006065B1 (en) | Toothpaste composition effective for caries and periodontal disease | |
| JP2019196329A (en) | Periodontal disease prevention oral composition | |
| KR101635861B1 (en) | Oral composition containing fermentative extract of galla rhoids as active ingredient | |
| KR19980013946A (en) | Oral composition of liquid type | |
| EP2399576B1 (en) | Use of antibacterial compounds for the oral cavity hygiene | |
| KR101480690B1 (en) | Oral composition containing natural extract | |
| KR101518832B1 (en) | Oral composition for effective plaque care | |
| KR100637653B1 (en) | Oral composition for bad breath | |
| KR101816638B1 (en) | Oral composition comprising saponin extracted from the root of Camellia sinensis | |
| KR101104548B1 (en) | Antimicrobial Toothpaste Composition | |
| KR102509579B1 (en) | Oral composition comprising cassava extract | |
| KR101703269B1 (en) | Oral care composition comprising Magnolia officinalis extract and bicarbonate | |
| US20060147391A1 (en) | Composition for enhancing oral health | |
| JPH1045550A (en) | Oral hygiene-promoting composition | |
| US5316760A (en) | Mouth-care products | |
| KR102597684B1 (en) | Oral composition comprising amaranth extract | |
| JP5665280B2 (en) | Oral composition | |
| KR20020082308A (en) | Composition for the mouth containing extraction of Euonymus alatus Sieb | |
| KR20160147523A (en) | Composition for promoting oral hygiene | |
| KR102827403B1 (en) | Composition for teeth whitening and antibacterial for oral microorganisms comprising apple extract | |
| KR101344803B1 (en) | Oral care composition comprising extract of machilus thunbergii and sequestering agent | |
| KR20110128961A (en) | Oral composition containing green tea extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-3-3-R10-R11-asn-PN2301 St.27 status event code: A-3-3-R10-R13-asn-PN2301 |
|
| A201 | Request for examination | ||
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
Fee payment year number: 1 St.27 status event code: A-2-2-U10-U11-oth-PR1002 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-4-4-P10-P22-nap-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |
|
| PR1001 | Payment of annual fee |
Fee payment year number: 4 St.27 status event code: A-4-4-U10-U11-oth-PR1001 |
|
| PC1903 | Unpaid annual fee |
Not in force date: 20220104 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE St.27 status event code: A-4-4-U10-U13-oth-PC1903 |
|
| K11-X000 | Ip right revival requested |
St.27 status event code: A-6-4-K10-K11-oth-X000 |
|
| PC1903 | Unpaid annual fee |
Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20220104 St.27 status event code: N-4-6-H10-H13-oth-PC1903 |
|
| PR0401 | Registration of restoration |
St.27 status event code: A-6-4-K10-K13-oth-PR0401 |
|
| R401 | Registration of restoration | ||
| PR1001 | Payment of annual fee |
Fee payment year number: 5 St.27 status event code: A-4-4-U10-U11-oth-PR1001 |
|
| PR1001 | Payment of annual fee |
Fee payment year number: 6 St.27 status event code: A-4-4-U10-U11-oth-PR1001 |
|
| PR1001 | Payment of annual fee |
Fee payment year number: 7 St.27 status event code: A-4-4-U10-U11-oth-PR1001 |
|
| PR1001 | Payment of annual fee |
Fee payment year number: 8 St.27 status event code: A-4-4-U10-U11-oth-PR1001 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R11-asn-PN2301 St.27 status event code: A-5-5-R10-R13-asn-PN2301 |